文献速递炎症性肠病

系统综述:胃肠道感染与新发炎症性肠病

Systematic review: gastrointestinal infection and incident inflammatory bowel disease.
PubMed 文献 · Aliment Pharmacol Ther · 2020-05-05

该系统综述检索截至2020年2月的电子数据库,纳入63项符合标准的研究,分析胃肠道感染与新发IBD风险的关联。结果显示沙门菌属、弯曲杆菌属和艰难梭菌等细菌以及诺如病毒与新发IBD风险增加相关,而幽门螺杆菌和蠕虫感染与风险降低相关。

要点

  • 沙门菌、弯曲杆菌、艰难梭菌与诺如病毒与新发IBD风险增加相关
  • 幽门螺杆菌和蠕虫感染与新发IBD风险降低相关
  • 需前瞻性研究明确这些肠道病原体的临床意义

核心结论

  • 某些肠道病原体与新发IBD风险增加相关,而另一些可能具有保护作用。

研究设计与样本

  • 系统综述检索截至2020年2月的电子数据库,63项研究符合完整纳入标准。

主要发现

  • 细菌中沙门菌属、弯曲杆菌属和艰难梭菌与新发IBD风险呈一致正相关。
  • 病毒中诺如病毒与新发克罗恩病风险增加相关。
  • 幽门螺杆菌和蠕虫感染与新发IBD风险降低呈总体一致相关。
  • 基于转化数据的定性分析提示涉及多种微生物和免疫通路机制。

临床怎么用

  • 对于有胃肠道感染史的患者,临床医生应意识到其与新发IBD风险的潜在关联。

局限性

  • 需前瞻性研究来阐明这些肠道病原体对新发IBD风险和病程的临床意义。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The initiating events of chronic gastrointestinal (GI) inflammation in Crohn's disease (CD) and ulcerative colitis (UC) are not well-defined, but GI infections are implicated. AIMS: To define the role of GI infections in risk of incident inflammatory bowel disease (IBD) and synthesise the current body of relevant translational data to provide biological context for associations between GI infections and IBD risk. METHODS: We systematically reviewed electronic databases through February 2020. Clinical studies that provided risk estimates of the association between GI infections and incident IBD were included. Inclusion criteria were broader for translational studies aiming to define mechanisms of GI infections and predisposition to or protection from IBD. RESULTS: Of the studies identified, 63 met full inclusion criteria. Among studies of clinical gastroenteritis, bacteria-specifically, Salmonella species, Campylobacter species and Clostridioides difficile-demonstrated consistent positive associations with risk of incident IBD. Of viruses, norovirus was associated with increased risk of incident CD. Regarding inverse associations with incident IBD, Helicobacter pylori and helminth infections were associated with a generally consistent reduced risk of IBD. Based on a qualitative analysis of the translational data, putative mechanisms involve multiple microbial and immunologic pathways. CONCLUSIONS: Based on this systematic review, certain enteric pathogens are associated with an increased risk of incident IBD, while others are potentially protective. Prospective studies are required to clarify the clinical implications of these enteric pathogens on the risk and course of IBD, and possible therapeutic or preventative benefit.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Axelrad JE, Cadwell KH, Colombel JF, et al. Systematic review: gastrointestinal infection and incident inflammatory bowel disease. Aliment Pharmacol Ther. 2020. PMID: 32372471. doi:10.1111/apt.15770

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。